Two Sigma Advisers
AUPH icon

Two Sigma Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Two Sigma Advisers’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,305,800
Closed -$20.8M – 204
2025
Q4 		$20.8M Buy
1,305,800
+825,900
+172% +$11.7M 0.04% 340
2025
Q3 		$5.3M Buy
479,900
+301,900
+170% +$3.3M 0.01% 726
2025
Q2 		$1.51M Buy
178,000
+50,000
+39% +$401K ﹤0.01% 1254
2025
Q1 		$1.03M Buy
+128,000
New +$1.04M ﹤0.01% 1460
2024
Q1 		– Sell
-149,900
Closed -$1.35M – 2454
2023
Q4 		$1.35M Sell
149,900
-433,000
-74% -$3.57M ﹤0.01% 1485
2023
Q3 		$4.53M Sell
582,900
-177,200
-23% -$1.73M 0.01% 791
2023
Q2 		$7.36M Buy
760,100
+471,800
+164% +$4.9M 0.02% 604
2023
Q1 		$3.16M Buy
288,300
+209,100
+264% +$1.84M 0.01% 1025
2022
Q4 		$342K Buy
79,200
+15,000
+23% +$87K ﹤0.01% 2021
2022
Q3 		$483K Buy
+64,200
New +$556K ﹤0.01% 1853
2020
Q4 		– Sell
-56,800
Closed -$837K – 2385
2020
Q3 		$837K Sell
56,800
-30,400
-35% -$440K ﹤0.01% 1585
2020
Q2 		$1.42M Buy
87,200
+13,400
+18% +$215K ﹤0.01% 1402
2020
Q1 		$1.07M Buy
+73,800
New +$1.3M ﹤0.01% 1449
2019
Q2 		– Sell
-10,900
Closed -$71K – 2307
2019
Q1 		$71K Buy
+10,900
New +$72.3K ﹤0.01% 2216
2018
Q3 		– Sell
-25,900
Closed -$146K – 2228
2018
Q2 		$146K Sell
25,900
-12,000
-32% -$66.9K ﹤0.01% 2240
2018
Q1 		$197K Sell
37,900
-10,500
-22% -$56.2K ﹤0.01% 2152
2017
Q4 		$219K Sell
48,400
-7,100
-13% -$39.4K ﹤0.01% 2059
2017
Q3 		$348K Buy
55,500
+8,900
+19% +$56.1K ﹤0.01% 1872
2017
Q2 		$286K Buy
+46,600
New +$314K ﹤0.01% 2009

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Advisers's AUPH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2026, closing a stake of 1,305,800 shares — an estimated $20.8M sold.

Two Sigma Advisers first reported a position in AUPH in Q2 2017 and held it in 19 quarters. The position peaked at $20.8M in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Two Sigma Advisers reported no remaining Aurinia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,305,800 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $20.8M.
  • Two Sigma Advisers first reported a position in Aurinia Pharmaceuticals in Q2 2017 and held it in 19 quarters.
  • Two Sigma Advisers's Aurinia Pharmaceuticals position peaked at $20.8M in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.